A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01496742
Recruitment Status : Completed
First Posted : December 21, 2011
Last Update Posted : September 23, 2016
Information provided by (Responsible Party):
Genentech, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2015
  Study Completion Date : November 2015